Signal transducer and activator of transcription proteins in leukemias.
about
The tumor suppressor hTid1 inhibits STAT5b activity via functional interactionMechanisms of STAT protein activation by oncogenic KIT mutants in neoplastic mast cellsSurvivin and Tumorigenesis: Molecular Mechanisms and Therapeutic StrategiesNucleic acid-based approaches to STAT inhibitionRole of calcium-dependent protein kinases in chronic myeloid leukemia: combined effects of PKC and BCR-ABL signaling on cellular alterations during leukemia developmentUnderstanding the pathogenesis of Kawasaki disease by network and pathway analysisZFP36L1 negatively regulates erythroid differentiation of CD34+ hematopoietic stem cells by interfering with the Stat5b pathwayEarly-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutationsSTAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-alpha3.Inhibition of monocytic differentiation by phosphorylation-deficient Stat1 is associated with impaired expression of Stat2, ICSBP/IRF8 and C/EBPepsilonHes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signallingReprogramming of lysosomal gene expression by interleukin-4 and Stat6Herpesvirus ateles Tio can replace herpesvirus saimiri StpC and Tip oncoproteins in growth transformation of monkey and human T cellsTyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B betaMultifaceted intervention by the Hsp90 inhibitor ganetespib (STA-9090) in cancer cells with activated JAK/STAT signalingDistinct patterns of DNA damage response and apoptosis correlate with Jak/Stat and PI3kinase response profiles in human acute myelogenous leukemiaSTAT6 expression in glioblastoma promotes invasive growthGenetic reprogramming of tumor cells by zinc finger transcription factorsTumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5.Human herpesvirus 8-encoded cytokines.Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells.Novel regulation of CCL2 gene expression by murine LITAF and STAT6B.Signal transducer and activator of transcription 3 (STAT3) gene polymorphisms are associated with treatment outcomes in acute myeloid leukemia.The Biology and Targeting of FLT3 in Pediatric Leukemia.A molecular model for the differential activation of STAT3 and STAT6 by the herpesviral oncoprotein tip.STAT3 supports experimental K-RasG12D-induced murine myeloproliferative neoplasms dependent on serine phosphorylation.Critical role of STAT3 in melanoma metastasis through anoikis resistanceDegradation of the transcription factors NF-κB, STAT3, and STAT5 is involved in Entamoeba histolytica-induced cell death in Caco-2 colonic epithelial cells.FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signalingLyn- and PLC-beta3-dependent regulation of SHP-1 phosphorylation controls Stat5 activity and myelomonocytic leukemia-like disease.Functional pathway analysis using SCNP of FLT3 receptor pathway deregulation in AML provides prognostic information independent from mutational statusNeovascularization of ischemic myocardium by newly isolated tannins prevents cardiomyocyte apoptosis and improves cardiac functionInhibition of STAT3-interacting protein 1 (STATIP1) promotes STAT3 transcriptional up-regulation and imatinib mesylate resistance in the chronic myeloid leukemia.Canonical and non-canonical JAK-STAT signaling.STAT3 induces anoikis resistance, promotes cell invasion and metastatic potential in pancreatic cancer cells.Direct activation of STAT5 by ETV6-LYN fusion protein promotes induction of myeloproliferative neoplasm with myelofibrosis.Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells.Loss of STAT3 in Lymphoma Relaxes NK Cell-Mediated Tumor SurveillanceHS-543 induces apoptosis of Imatinib-resistant chronic myelogenous leukemia with T315I mutation.Role of intracellular tyrosines in activating KIT-induced myeloproliferative disease
P2860
Q24308570-4FDD6083-175C-4EE4-B156-07371DE91029Q24313261-1C269201-600B-402F-A97C-5A4151F3FD2DQ26766250-3064E61D-5F58-4BF2-997F-8B1D902B509BQ26822830-721C63E9-D551-4AB5-8A64-F6ED0BCF85D5Q26861674-3A07D0C3-9E14-488A-A024-97DA1BC9B8FFQ26996702-4F0BF4BB-F274-42AF-8C93-4467D4A5DF72Q28119162-5E54D448-0DF5-4ED1-A954-D5B571918ED2Q28250725-360C5731-E117-4AAC-B46F-7FCD8B5AF006Q28253106-3CF9DA23-A0B2-4D54-A934-3648E4529A6CQ28258688-D51E6562-2EEE-4946-B6DC-C7BD0235446AQ28262816-1984DF5D-998A-4962-A339-36CC7F1B49FCQ28393663-FBAF3CD3-7863-4C48-AACA-7E33A6309ABAQ28396253-E134F577-C173-463C-A572-5C4DA289AC3FQ28506708-5114E7D3-92FC-4479-89A7-0419016AB82BQ28741023-B1AD713A-862C-4274-8BDE-6FD868D4B6CBQ28749564-73FD66C6-A251-42CF-8FE7-1B85551CB203Q30431789-4FDAD1A8-246F-47CA-A731-0D3302371E52Q33221141-68B12776-E4AB-4663-9D7B-47B2DC5C1B5EQ33289385-EC159B66-006E-4D78-8F43-72650F9BB9BDQ33813244-DBB5F6D6-FB58-4A1D-B49C-2C37FA21F238Q33931707-7C03AB70-896C-4B80-99E0-BCB1C21F4AD9Q34042924-738E9F36-7089-4984-91C0-D7E178355DB2Q34178810-573DDF78-E6AC-4B36-91EE-11E029FE7A9EQ34229555-F7A65C9C-E1B6-4717-83DA-03109A9BA890Q34235138-F4932DAA-0111-4381-A452-3CFDEBDFA9F8Q34284326-E6B047B3-C885-49F0-81A2-EF01FB41F0A2Q34334499-FA61A71A-571B-4314-87B8-622C210CF9E1Q34411011-1E20C6BC-7B53-4034-A487-CDA244ED50A6Q34459845-A1937353-766F-47EB-8157-6520B8D9AD1DQ34541593-A6FBCF9F-0FFB-43E9-BEE3-53FD818B5F4AQ34595162-C857B1E7-FF93-4928-BF18-19CBB1C8346AQ34611563-07D36FEE-06E0-4EE6-B152-DCA001CD3F08Q34650656-4A72495E-EF88-4388-8BC1-C90BBF0D60BAQ34855617-D96356B6-32F5-4D97-9773-31AC912E6CF3Q34918045-AC15236C-4DDD-4459-9961-E7096C3F1EA6Q34969897-48B9BFBB-DEEE-48FB-B42E-27367ADFD6D0Q35085222-0F06DA8F-97A3-4C61-8E5F-458F739C11BAQ35086418-847F1DF2-8697-4F58-B5F3-8193C287C0F4Q35176353-282B763A-9604-41A0-BE39-4B3118D17ED7Q35230318-53225D36-DE56-47BD-8418-1AFC5BE004D2
P2860
Signal transducer and activator of transcription proteins in leukemias.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Signal transducer and activator of transcription proteins in leukemias.
@ast
Signal transducer and activator of transcription proteins in leukemias.
@en
type
label
Signal transducer and activator of transcription proteins in leukemias.
@ast
Signal transducer and activator of transcription proteins in leukemias.
@en
prefLabel
Signal transducer and activator of transcription proteins in leukemias.
@ast
Signal transducer and activator of transcription proteins in leukemias.
@en
P2093
P1433
P1476
Signal transducer and activator of transcription proteins in leukemias
@en
P2093
Heinz Baumann
Maria R Baer
Meir Wetzler
P304
P356
10.1182/BLOOD-2002-04-1204
P407
P577
2002-12-12T00:00:00Z